Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 23,149-23,160 of 23,847
Behavioral study icon
CompletedNCT05140109

study on Three Eating disorders Group Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In Paris
Eating disordersBehavioralOver 18 Years
Countries
France
Sponsor
Université Lumière Lyon 2
Condition
Eating disorders
Drug study icon
CompletedNCT03872596

study to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In Long Beach
Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT03198078

study Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In Oklahoma City
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Behavioral study icon
Active Not RecruitingNCT05967195

study to Increase FEP Attendance

This study is looking at whether Financial Incentive and Text-Messages can help people with First-Episode Psychosis. Participants take part in Financial Incentive and Text-Messages and complete follow-up assessments.

Multiple locations, including Raleigh
SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Schizophrenia
Drug study icon
TerminatedNCT04421456

Study to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in people with Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

This study was terminated in the United States, in Poland, in Serbia, .... It focuses on schizophrenia.

Multiple locations, including Bentonville
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Poland, Serbia, ...
Sponsor
Jazz Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.